A glance at what’s happening in the world of technology.
Gene inhibitor could slow progress of PVR
The topical delivery of a gene transcription factor inhibitor curbed the progression of proliferative vitreoretinopathy (PVR) in a study using rabbits.
PVR remains without an effective prophylactic or therapeutic medical treatment and is the leading cause of retinal detachment surgery failure.
Sign in to continue
Not already a member of The College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.